未登录

T

Tista Roy Chaudhuri

University of Duisburg-Essen

H指数:6

被引数:130

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Systematic Evaluation of Physicochemical Properties of PEGylated Gold Nanorods Reveals Cell-Specific Uptake Determinants in Human Immune Cell Subsets

系统评价聚乙二醇化金纳米棒的物理化学性质揭示了在人类免疫细胞亚群中的细胞特异性摄取决定因素

IF8.3

2026-03-050

OAAI

Magnetic chromatography improves colloidal and MRI attributes of magnetoliposomes enabling evaluation of the impact of size on bio-distribution in an in vivo model of pancreatic cancer

JOURNAL OF MATERIALS CHEMISTRY B

IF5.7

2025-01-010

PRE

Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness

DRUG RESISTANCE UPDATES

IF21.7

2024-03-011

PRE

Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors

CLINICAL CANCER RESEARCH

IF10.2

2024-01-251

OA

Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-agent fibroblast growth factor receptor-specific inhibitors in pancreatic cancer

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2024-01-222

PRE

Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition

ACTA BIOMATERIALIA

IF9.6

2023-03-016

OAAI

Formation of hydrated PEG layers on magnetic iron oxide nanoflowers shows internal magnetisation dynamics and generates high in-vivo efficacy for MRI and magnetic hyperthermia

ACTA BIOMATERIALIA

IF9.6

2022-10-0111

OAAI

FGFR1 inhibitor reverses Smoothened inhibition-induced epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma

CANCER RESEARCH

IF16.6

2017-07-010

PRE

FGFR inhibitors enhance gemcitabine sensitivity in pancreatic ductal adenocarcinoma

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Activity of an EphA2-targeted docetaxel nanoliposome in pancreatic patient-derived models as monotherapy and in combination with gemcitabine

CANCER RESEARCH

IF16.6

2016-07-151

PRE

Tumor-Priming Smoothened Inhibitor Enhances Deposition and Efficacy of Cytotoxic Nanoparticles in a Pancreatic Cancer Model

MOLECULAR CANCER THERAPEUTICS

IF5.5

2016-01-0740

OAAI

Mechanisms of Tumor Vascular Priming by a Nanoparticulate Doxorubicin Formulation

PHARMACEUTICAL RESEARCH

IF4.3

2012-07-1418

OA

Effects of sonic Hedgehog inhibitor combined with nanoparticulate drug delivery on vascular permeability and efficacy in a pancreatic cancer model

CANCER RESEARCH

IF16.6

2012-04-010

PRE

Methyl dynamics for understanding hydrophobic core packing of dynamically different motifs of double-stranded RNA binding domain of protein kinase R

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

IF2.8

2005-11-186

PREAI